Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Zohre Momenimovahed, Azita Tiznobaik, Safoura Taheri & Hamid Salehiniya. (2019) Ovarian cancer in the world: epidemiology and risk factors. International Journal of Women's Health 11, pages 287-299.
Read now
Read now
Articles from other publishers (52)
Zhipeng Fan, Hongfei Song, Rongli Yuan, Yangzhi Peng & Yong Jiang. (2023) Genetic predisposition to female infertility in relation to epithelial ovarian and endometrial cancers. Postgraduate Medical Journal 99:1168, pages 63-68.
Crossref
Crossref
Liang Yu, Jiafan Sun, Qiqin Wang, Wennian Yu, Anqi Wang, Shu Zhu, Wei Xu & Xiuli Wang. (2023) Ovulation induction drug and ovarian cancer: an updated systematic review and meta-analysis. Journal of Ovarian Research 16:1.
Crossref
Crossref
Lidia A. Klyukina, Elena A. Sosnova & Anton А. Ishchenko. (2022) Assisted reproductive technology and uterine cancer risk. A systematic review and meta-analysis. Journal of obstetrics and women's diseases 71:3, pages 77-86.
Crossref
Crossref
Lidiya A. Klyukina, Elena A. Sosnova & Anton A. Ishchenko. (2022) The stimulation of ovulation and endometrial carcinogenesis: possible relationship and study prospects (literature review). V.F.Snegirev Archives of Obstetrics and Gynecology 9:2, pages 73-81.
Crossref
Crossref
Pulak R. Manna, Ahsen U. Ahmed, Deborah Molehin, Madhusudhanan Narasimhan, Kevin Pruitt & P. Hemachandra Reddy. (2022) Hormonal and Genetic Regulatory Events in Breast Cancer and Its Therapeutics: Importance of the Steroidogenic Acute Regulatory Protein. Biomedicines 10:6, pages 1313.
Crossref
Crossref
R Machtinger, N Fallach, I Goldstein, G Chodick, E Schiff, R Orvieto & R Mashiach. (2022) Ovarian stimulation for fertility treatments and risk of breast cancer: a matched cohort study. Human Reproduction 37:3, pages 577-585.
Crossref
Crossref
V.O. Berestovyi, A. Mahmood, A.M. Martych, A.B. Prylutska, O.O. Berestovyi & D.O. Govsieiev. (2021) Prospective study to estimate the role of different infertility factors in prediction of unsuccessful IVF outcome. REPRODUCTIVE ENDOCRINOLOGY:62, pages 14-21.
Crossref
Crossref
Yusuf Beebeejaun, Abbeyrahmee Athithan, Timothy P. Copeland, Mohan S. Kamath, Ippokratis Sarris & Sesh K. Sunkara. (2021) Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis. Fertility and Sterility 116:1, pages 198-207.
Crossref
Crossref
Jennifer Frances Barcroft, Nicolas Galazis, Benjamin P Jones, Natalie Getreu, Timothy Bracewell-Milnes, Karen J Grewal, Flavia Sorbi, Joseph Yazbek, Kostas Lathouras, J Richard Smith, Paul Hardiman, Meen-Yau Thum, Jara Ben-Nagi, Sadaf Ghaem-Maghami, Jan Verbakel & Srdjan Saso. (2021) Fertility treatment and cancers—the eternal conundrum: a systematic review and meta-analysis. Human Reproduction 36:4, pages 1093-1107.
Crossref
Crossref
Sonia Guleria, Allan Jensen, Vanna Albieri, Bugge Nøhr, Kirsten Frederiksen & Susanne K. Kjær. (2021) Endometrial cancer risk after fertility treatment: a population-based cohort study. Cancer Causes & Control 32:2, pages 181-188.
Crossref
Crossref
Yu‐Ting Jiang, Ting‐Ting Gong, Jia‐Yu Zhang, Xiu‐Qin Li, Song Gao, Yu‐Hong Zhao & Qi‐Jun Wu. (2020) Infertility and ovarian cancer risk: Evidence from nine prospective cohort studies. International Journal of Cancer 147:8, pages 2121-2130.
Crossref
Crossref
J. Raad, L. Rolland, M. Grynberg, B. Courbiere & E. Mathieu d’Argent. (2020) Tumeurs frontières de l’ovaire. Recommandations pour la pratique clinique du CNGOF – Fertilité. Gynécologie Obstétrique Fertilité & Sénologie 48:3, pages 330-336.
Crossref
Crossref
Sonia Guleria, Susanne K. Kjær, Vanna Albieri, Kirsten Frederiksen & Allan Jensen. (2019) A Cohort Study of Breast Cancer Risk after 20 Years of Follow-Up of Women Treated with Fertility Drugs. Cancer Epidemiology, Biomarkers & Prevention 28:12, pages 1986-1992.
Crossref
Crossref
Darja Arko & Iztok Takac. (2019) Inquiry and computer program Onko-Online: 25 years of clinical registry for breast cancer at the University Medical Centre Maribor. Radiology and Oncology 53:3, pages 348-356.
Crossref
Crossref
Ivana Rizzuto, Renee F Behrens & Lesley A Smith. (2019) Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane Database of Systematic Reviews 2019:6.
Crossref
Crossref
Zohre Momenimovahed, Safoura Taheri, Azita Tiznobaik & Hamid Salehiniya. (2019) Do the Fertility Drugs Increase the Risk of Cancer? A Review Study. Frontiers in Endocrinology 10.
Crossref
Crossref
Frida E. Lundberg, Anastasia N. Iliadou, Kenny Rodriguez-Wallberg, Kristina Gemzell-Danielsson & Anna L. V. Johansson. (2019) The risk of breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based study. European Journal of Epidemiology 34:5, pages 499-507.
Crossref
Crossref
Irene Woo & Richard J. Paulson. 2018. Encyclopedia of Reproduction. Encyclopedia of Reproduction
40
49
.
Shruti Parikh & Christophe Blockeel. 2018. Preventing Age Related Fertility Loss. Preventing Age Related Fertility Loss
125
139
.
Lindsay Kroener, Daniel Dumesic & Zain Al-Safi. (2017) Use of fertility medications and cancer risk: a review and update. Current Opinion in Obstetrics & Gynecology 29:4, pages 195-201.
Crossref
Crossref
Marte Myhre Reigstad, Ritsa Storeng, Tor Åge Myklebust, Nan Birgitte Oldereid, Anne Katerine Omland, Trude Eid Robsahm, Louise Annette Brinton, Siri Vangen, Kari Furu & Inger Kristin Larsen. (2017) Cancer Risk in Women Treated with Fertility Drugs According to Parity Status—A Registry-based Cohort Study. Cancer Epidemiology, Biomarkers & Prevention 26:6, pages 953-962.
Crossref
Crossref
Irene Woo & Richard J. Paulson. 2017. Handbook of In Vitro Fertilization. Handbook of In Vitro Fertilization
303
316
.
Alkistis Skalkidou, Theodoros N Sergentanis, Spyros P Gialamas, Marios K Georgakis, Theodora Psaltopoulou, Marialena Trivella, Charalampos S Siristatidis, Evangelos Evangelou & Eleni Petridou. (2017) Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility. Cochrane Database of Systematic Reviews 2017:3.
Crossref
Crossref
Amin Philip Makar. 2017. Complications and Outcomes of Assisted Reproduction. Complications and Outcomes of Assisted Reproduction
1
14
.
Brent Hanson, Erica Johnstone, Jessie Dorais, Bob Silver, C. Matthew Peterson & James Hotaling. (2016) Female infertility, infertility-associated diagnoses, and comorbidities: a review. Journal of Assisted Reproduction and Genetics 34:2, pages 167-177.
Crossref
Crossref
Allison L. Goetsch, Dana Kimelman & Teresa K. WoodruffAllison L. Goetsch, Dana Kimelman & Teresa K. Woodruff. 2017. Fertility Preservation and Restoration for Patients with Complex Medical Conditions. Fertility Preservation and Restoration for Patients with Complex Medical Conditions
285
300
.
Samantha Pfeifer, Samantha Butts, Daniel Dumesic, Gregory Fossum, Clarisa Gracia, Andrew La Barbera, Jennifer Mersereau, Randall Odem, Richard Paulson, Alan Penzias, Margareta Pisarska, Robert Rebar, Richard Reindollar, Mitchell Rosen, Jay Sandlow, Michael Vernon & Eric Widra. (2016) Fertility drugs and cancer: a guideline. Fertility and Sterility 106:7, pages 1617-1626.
Crossref
Crossref
Ignacio Zapardiel, Maria Cruz, Maria D. Diestro, Antonio Requena & Juan A. Garcia-Velasco. (2016) Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers. Human Reproduction Update 22:3, pages 281-305.
Crossref
Crossref
R. Kessous, E. Davidson, M. Meirovitz, R. Sergienko & E. Sheiner. (2015) The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up. Journal of Cancer Research and Clinical Oncology 142:1, pages 287-293.
Crossref
Crossref
Srdjan Saso, Louay S. Louis, Farah Doctor, Ali Hassan Hamed, Jayanta Chatterjee, Joseph Yazbek, Shabana Bora, Hossam Abdalla, Sadaf Ghaem-Maghami & Meen-Yau Thum. (2015) Does fertility treatment increase the risk of uterine cancer? A meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology 195, pages 52-60.
Crossref
Crossref
Barbara Luke, Morton B. Brown, Logan G. Spector, Stacey A. Missmer, Richard E. Leach, Melanie Williams, Lori Koch, Yolanda Smith, Judy E. Stern, G. David Ball & Maria J. Schymura. (2015) Cancer in women after assisted reproductive technology. Fertility and Sterility 104:5, pages 1218-1226.
Crossref
Crossref
Jing Zhao, Yanping Li, Qiong Zhang & Yonggang Wang. (2015) RETRACTED: Does ovarian stimulation for IVF increase gynaecological cancer risk? A systematic review and meta-analysis. Reproductive BioMedicine Online 31:1, pages 20-29.
Crossref
Crossref
Tamar Perri, Dror Lifshitz, Siegal Sadetzki, Bernice Oberman, Dror Meirow, Gilad Ben-Baruch, Eitan Friedman & Jacob Korach. (2015) Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers. Fertility and Sterility 103:5, pages 1305-1312.
Crossref
Crossref
Alessandra Gennari, Mauro Costa, Matteo Puntoni, Laura Paleari, Andrea De Censi, Maria Pia Sormani, Nicoletta Provinciali & Paolo Bruzzi. (2015) Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies. Breast Cancer Research and Treatment 150:2, pages 405-413.
Crossref
Crossref
H P Yang, L S Cook, E Weiderpass, H-O Adami, K E Anderson, H Cai, J R Cerhan, T V Clendenen, A S Felix, C M Friedenreich, M Garcia-Closas, M T Goodman, X Liang, J Lissowska, L Lu, A M Magliocco, S E McCann, K B Moysich, S H Olson, S Petruzella, M C Pike, S Polidoro, F Ricceri, H A Risch, C Sacerdote, V W Setiawan, X O Shu, A B Spurdle, B Trabert, P M Webb, N Wentzensen, Y-B Xiang, Y Xu, H Yu, A Zeleniuch-Jacquotte & L A Brinton. (2015) Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2). British Journal of Cancer 112:5, pages 925-933.
Crossref
Crossref
Marte Myhre Reigstad, Inger Kristin Larsen, Tor Åge Myklebust, Trude Eid Robsahm, Nan Birgitte Oldereid, Anne Katerine Omland, Siri Vangen, Louise Annette Brinton & Ritsa Storeng. (2015) Risk of breast cancer following fertility treatment-A registry based cohort study of parous women in Norway. International Journal of Cancer 136:5, pages 1140-1148.
Crossref
Crossref
M. Jégu, A. Some Der, K. Morcel, C. Abadie, X. Fritel & J. Levêque. (2015) Cancers du sein et de l’ovaire liés aux mutations constitutionnelles délétères BRCA1&2 et reproduction : revue de la littérature. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 44:1, pages 10-17.
Crossref
Crossref
Dominic Stoop, Ana Cobo & Sherman Silber. (2014) Fertility preservation for age-related fertility decline. The Lancet 384:9950, pages 1311-1319.
Crossref
Crossref
K. von Horn, M. Depenbusch, A. Schultze-Mosgau & G. Griesinger. (2014) Krebsrisiko nach ovarieller StimulationCancer risk with ovarian stimulation. Gynäkologische Endokrinologie 12:3, pages 162-166.
Crossref
Crossref
Federica Tomao, Giuseppe Lo Russo, Gian Paolo Spinelli & Silverio Tomao. (2014) Clinical use of fertility agents and risk of breast cancer. Current Opinion in Obstetrics & Gynecology 26:3, pages 130-137.
Crossref
Crossref
Louise A. Brinton, Bert Scoccia, Kamran S. Moghissi, Carolyn L. Westhoff, Shelley Niwa, David Ruggieri, Britton Trabert & Emmet J. Lamb. (2014) Long-term Relationship of Ovulation-Stimulating Drugs to Breast Cancer Risk. Cancer Epidemiology, Biomarkers & Prevention 23:4, pages 584-593.
Crossref
Crossref
Aus Tariq Ali. (2014) Reproductive Factors and the Risk of Endometrial Cancer. International Journal of Gynecologic Cancer 24:3, pages 384-393.
Crossref
Crossref
Bassma Mohamed El Sabaa. (2014) Pathological conditions predisposing to infertility and gynaecological neoplasia. World Journal of Obstetrics and Gynecology 3:2, pages 28.
Crossref
Crossref
Federica Tomao, Giuseppe Lo Russo, Gian Spinelli, Valeria Stati, Alessandra Prete, Natalie Prinzi, Marsela Sinjari, Patrizia Vici, Anselmo Papa, Maria Chiotti, Pierluigi Benedetti Panici & Silverio Tomao. (2014) Fertility drugs, reproductive strategies and ovarian cancer risk. Journal of Ovarian Research 7:1, pages 51.
Crossref
Crossref
Theodoros N. Sergentanis, Andreas-Antonios Diamantaras, Christina Perlepe, Prodromos Kanavidis, Alkistis Skalkidou & Eleni Th. Petridou. (2014) IVF and breast cancer: a systematic review and meta-analysis. Human Reproduction Update 20:1, pages 106-123.
Crossref
Crossref
Serkan Yilmaz, Fatma Ünal, Ebru Yilmaz, Deniz Yüzbaşioğlu & Sibel Erkal İlhan. (2014) Evaluation of the genotoxicity of clomiphene citrate. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 759, pages 21-27.
Crossref
Crossref
Britton Trabert, Emmet J. Lamb, Bert Scoccia, Kamran S. Moghissi, Carolyn L. Westhoff, Shelley Niwa & Louise A. Brinton. (2013) Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort. Fertility and Sterility 100:6, pages 1660-1666.
Crossref
Crossref
L. A. Brinton, C. L. Westhoff, B. Scoccia, E. J. Lamb, B. Trabert, S. Niwa & K. S. Moghissi. (2013) Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort. Human Reproduction 28:10, pages 2813-2821.
Crossref
Crossref
Ivana Rizzuto, Renee F Behrens & Lesley A Smith. (2013) Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Susanne Schüler, Marvin Ponnath, Jörg Engel & Olaf Ortmann. (2013) Ovarian epithelial tumors and reproductive factors: a systematic review. Archives of Gynecology and Obstetrics 287:6, pages 1187-1204.
Crossref
Crossref
Louise A. Brinton, Britton Trabert, Varda Shalev, Eitan Lunenfeld, Tal Sella & Gabriel Chodick. (2013) In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services. Fertility and Sterility 99:5, pages 1189-1196.
Crossref
Crossref
Ritsa Storeng, Siri Vangen, Anne Katerine Omland & Nan Birgitte Oldereid. (2012) Infertilitetsbehandling og kreftrisiko. Tidsskrift for Den norske legeforening 132:22, pages 2494-2499.
Crossref
Crossref